|
FLVCR1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.769200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.814200E-01 |
| Normal-vs-Stage2 |
3.447400E-01 |
| Normal-vs-Stage3 |
3.716200E-01 |
| Normal-vs-Stage4 |
2.552600E-01 |
| Stage1-vs-Stage2 |
2.226600E-01 |
| Stage1-vs-Stage3 |
4.772000E-01 |
| Stage1-vs-Stage4 |
3.186200E-01 |
| Stage2-vs-Stage3 |
1.307570E-01 |
| Stage2-vs-Stage4 |
1.013420E-01 |
| Stage3-vs-Stage4 |
7.313800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.315600E-01 |
| Normal-vs-AfricanAmerican |
1.582000E-02 |
| Normal-vs-Asian |
1.520810E-01 |
| Caucasian-vs-AfricanAmerican |
1.399850E-02 |
| Caucasian-vs-Asian |
1.337590E-01 |
| AfricanAmerican-vs-Asian |
7.115600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.214160E-01 |
| Normal-vs-Female |
2.102200E-01 |
| Male-vs-Female |
9.953200E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.232200E-02 |
| Normal-vs-Age(41-60Yrs) |
7.775800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.201400E-01 |
| Normal-vs-Age(81-100Yrs) |
9.903800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.042200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.682380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.710010E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.024600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.794800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.951400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.027600E-01 |
| Normal-vs-Grade 2 |
9.050600E-01 |
| Normal-vs-Grade 3 |
5.824800E-01 |
| Normal-vs-Grade 4 |
7.273600E-02 |
| Grade 1-vs-Grade 2 |
8.840600E-01 |
| Grade 1-vs-Grade 3 |
6.686600E-01 |
| Grade 1-vs-Grade 4 |
2.364800E-01 |
| Grade 2-vs-Grade 3 |
4.400200E-01 |
| Grade 2-vs-Grade 4 |
5.080400E-02 |
| Grade 3-vs-Grade 4 |
1.587010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.138600E-01 |
| Normal-vs-ccB subtype |
2.445400E-01 |
| ccA subtype-vs-ccB subtype |
6.560900E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.828200E-01 |
| Normal-vs-N1 |
7.976400E-01 |
| N0-vs-N1 |
9.617400E-01 |
|
|
